Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Pharma
FDA approves Ultragenyx gene therapy after prior rejection
Fayuvi marks the first FDA-approved therapy designed to treat the underlying disease of MPS IIIA, a rare genetic neurodegenerative disorder.
Angus Liu
Sep 17, 2026 4:50pm
Bayer’s Kerendia scores FDA nod for CKD in Type 1 diabetes
Sep 17, 2026 2:06pm
Clinical trials reach a new automation inflection point
Brought to you by
IQVIA
Roche reports positive confirmatory trial readout for Lunsumio
Sep 17, 2026 11:25am
Closing the gap between innovation and impact
Brought to you by
Diaceutics
Bavarian Nordic taps Sanofi vet to replace outgoing CEO Chaplin
Sep 17, 2026 11:16am
